prijavaregistracija

košarica

0.00 €
HPLC testiranoCOA vsaka serijaEU dostavaSEPA · varno plačiloResearch Use Only
PEPTIQA BIOTECHTesamorelin10 mgPurity 8% · RUO

Excellent

Ocena 4.8 / 5 — zgodnja ocena kakovosti

★Peptiqa Reviews

Zgodnja ocena kakovosti — po prvem verified nakupu lahko kupci objavijo mnenje.

Tesamorelin

10 mg8% purityLot #TESAMO-2026-001

Šifra izbrane dimenzije: PEP-TESA-10MG

Tesamorelin is a synthetic peptide composed of 44 amino acids and represents a modified analog of growth hormone-releasing hormone (GHRH). A trans-3-hexenoic acid moiety has been added to its N-terminal region, enhancing its stability and prolonging its biological half-life compared with endogenous GHRH. Marketed as Egrifta® and Egrifta SV®, it remains the only FDA-approved GHRH analog specifically authorized for the treatment of excess visceral abdominal fat in adults affected by HIV-associated lipodystrophy. Through selective stimulation of growth hormone secretion from the pituitary gland, Tesamorelin primarily reduces deep visceral adipose tissue while helping preserve both subcutaneous fat stores and lean body mass. Large randomized controlled trials have consistently demonstrated reductions in abdominal trunk fat and waist circumference, along with improvements in patient body image, without many of the adverse effects commonly associated with direct HGH administration.
€201.30z DDV
✅ Na zalogi (40)

Količinski popusti

KoličinaCena / kosPrihranek
1 vial201.30 €—
3 vials (−7%)186.66 €−7%
5 vials (−12%)176.90 €−12%
Nakup & zberi 165 točk!

Ocene in mnenja

Prijavite se in ocenite izdelek po prejetem naročilu. prijava

Certifikat analize

Lab Verified
✓Ogled COA pred nakupom — transparentnost zagotovljena
Raziskovalni profil

Tesamorelin — znanstveni profil

Vsebina je namenjena izobraževalnim in raziskovalnim namenom. Research Use Only.

  • Tesamorelin is a synthetic peptide composed of 44 amino acids and represents a modified analog of growth hormone-releasing hormone (GHRH). A trans-3-hexenoic acid moiety has been added to its N-terminal region, enhancing its stability and prolonging its biological half-life compared with endogenous GHRH. Marketed as Egrifta® and Egrifta SV®, it remains the only FDA-approved GHRH analog specifically authorized for the treatment of excess visceral abdominal fat in adults affected by HIV-associated lipodystrophy.
  • Through selective stimulation of growth hormone secretion from the pituitary gland, Tesamorelin primarily reduces deep visceral adipose tissue while helping preserve both subcutaneous fat stores and lean body mass. Large randomized controlled trials have consistently demonstrated reductions in abdominal trunk fat and waist circumference, along with improvements in patient body image, without many of the adverse effects commonly associated with direct HGH administration.

Več iz kategorije GH peptidi

BPC-157
BPC-157
€114.68
TB-500
TB-500
€119.56
Glutathione
Glutathione
€87.84
GHK-Cu
GHK-Cu
€103.70

Ta stran uporablja piškotke

Accept